Nanoparticle and targeted systems for cancer therapy

被引:1582
作者
Brannon-Peppas, L [1 ]
Blanchette, JO [1 ]
机构
[1] Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA
关键词
targeted delivery; nanoparticles; cancer therapy; angiogenesis; antibodies;
D O I
10.1016/j.addr.2004.02.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review explores recent work directed towards more targeted treatment of cancer, whether through more specific anticancer agents or through methods of delivery. These areas include delivery by avoiding the reticuloendothelial system, utilizing the enhanced permeability and retention effect and tumor-specific targeting. Treatment opportunities using antibody-targeted therapies are summarized. The ability to treat cancer by targeting delivery through angiogenesis is also discussed and antiangiogenic drugs in clinical trials are presented. Delivery methods that specifically use nanoparticles are also highlighted, including both degradable and nondegradable polymers. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:1649 / 1659
页数:11
相关论文
共 43 条
[1]   An overview of targeted treatments in cancer [J].
Abou-Jawde, R ;
Choueiri, T ;
Alemany, C ;
Mekhail, T .
CLINICAL THERAPEUTICS, 2003, 25 (08) :2121-2137
[2]   Toward selection of internalizing antibodies from phage libraries [J].
Becerril, B ;
Poul, MA ;
Marks, JD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (02) :386-393
[3]   A PEGylated dendritic nanoparticulate carrier of fluorouracil [J].
Bhadra, D ;
Bhadra, S ;
Jain, S ;
Jain, NK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 257 (1-2) :111-124
[4]   Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery [J].
Blessing, T ;
Kursa, M ;
Holzhauser, R ;
Kircheis, R ;
Wagner, E .
BIOCONJUGATE CHEMISTRY, 2001, 12 (04) :529-537
[5]   Nanoparticles in cancer therapy and diagnosis [J].
Brigger, I ;
Dubernet, C ;
Couvreur, P .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :631-651
[6]   Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy [J].
Chari, RVJ .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 31 (1-2) :89-104
[7]   Targeting tumor angiogenesis with gene therapy [J].
Chen, QR ;
Zhang, L ;
Gasper, W ;
Mixson, AJ .
MOLECULAR GENETICS AND METABOLISM, 2001, 74 (1-2) :120-127
[8]   VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer:: in vivo studies [J].
Dagar, S ;
Krishnadas, A ;
Rubinstein, I ;
Blend, MJ ;
Önyüksel, H .
JOURNAL OF CONTROLLED RELEASE, 2003, 91 (1-2) :123-133
[9]   Tumour vasculature as a target for anticancer therapy [J].
Eatock, MM ;
Schätzlein, A ;
Kaye, SB .
CANCER TREATMENT REVIEWS, 2000, 26 (03) :191-204
[10]   Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases [J].
Feng, SS ;
Chien, S .
CHEMICAL ENGINEERING SCIENCE, 2003, 58 (18) :4087-4114